Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial
古马隆替尼治疗携带MET 14号外显子跳跃突变的非小细胞肺癌患者：一项多中心、单臂、开放标签的1b/2期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.101952
Yu, Yongfeng; Zhou, Jianya; Li, Xingya; Goto, Koichi; Min, Xuhong; Nishino, Kazumi; Cui, Jiuwei; Wu, Lin; Sakakibara, Jun; Shu, Yongqian; Dong, Xiaorong; Li, Lu; Yoneshima, Yasuto; Zhou, Chengzhi; Li, Xiaoling; Zhang, Yiping; Huang, Dingzhi; Zang, Aimin; Zhang, Wei; Wang, Xiuwen; Zhang, Li; Bai, Chong; Fang, Jian; Cao, Lejie; Zhao, Yanqiu; Yu, Yan; Shi, Meiqi; Zhong, Diansheng; Li, Fugen; Li, Meng; Wu, Qiuxia; Zhou, Jun; Sun, Minghui; Lu, Shun
